The Current Ratio as of November 2024 (TTM) for Aptose Biosciences Inc. (APTO) is 1.05

According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.05. This represents a change of 16.51% compared to the average of 0.90 of the last 4 quarters.

Aptose Biosciences Inc. (APTO) Historical Current Ratio (quarterly & annually)

How has APTO Current Ratio performed in the past?

The mean historical Current Ratio of Aptose Biosciences Inc. over the last ten years is 9.23. The current 1.05 Current Ratio has changed 1.04% with respect to the historical average. Over the past ten years (40 quarters), APTO's Current Ratio was at its highest in in the September 2020 quarter at 24.60. The Current Ratio was at its lowest in in the December 2023 quarter at 0.78.

Aptose Biosciences Inc. (APTO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aptose Biosciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptose Biosciences Inc. (APTO) Average Current Ratio

How has APTO Current Ratio performed in the past?

The current Current Ratio of Aptose Biosciences Inc. (APTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptose Biosciences Inc. (APTO) Current Ratio vs. Peers

How is APTO’s Current Ratio compared to its peers?

Aptose Biosciences Inc.’s Current Ratio is greater than CytomX Therapeutics, Inc. (1.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), less than Spero Therapeutics, Inc. (2.68), less than Assembly Biosciences, Inc. (2.36), less than Fortress Biotech, Inc. (1.23), greater than Mustang Bio, Inc. (0.40), less than Achilles Therapeutics plc (6.04), less than Fortress Biotech, Inc. (1.23), less than Gain Therapeutics, Inc. (2.99), greater than TFF Pharmaceuticals, Inc. (0.89), less than aTyr Pharma, Inc. (6.07), less than IN8bio, Inc. (1.84), less than Lantern Pharma Inc. (8.31), less than Affimed N.V. (1.93), less than Leap Therapeutics, Inc. (3.97), less than Adaptimmune Therapeutics plc (3.85), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Longboard Pharmaceuticals, Inc. (15.97), greater than TRACON Pharmaceuticals, Inc. (0.66), less than Oncternal Therapeutics, Inc. (2.39), less than Aeglea BioTherapeutics, Inc. (4.59),

Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.